Special Offer! - Free Pharmacy Design - Limited Time Offer, Hurry Up & Register Now

My Cart
In stock

EPIRUBICIN HCL 2MG/ML 25 ML

In stock
Only 1 left
SKU
10331017834

Epirubicin HCl 2mg/mL 25mL is a potent chemotherapy injectable solution used to treat various cancers, including breast cancer and lymphomas. It is administered intravenously by healthcare professionals to inhibit cancer cell growth. Strict medical supervision is required due to its cytotoxic nature and potential side effects.

Product Overview

Epirubicin HCl 2mg/mL 25mL is a potent chemotherapy medication indicated for the treatment of various types of cancer. It belongs to the anthracycline class of cytotoxic agents, working by interfering with the DNA of cancer cells to inhibit their growth and replication. This injectable solution is specifically formulated for intravenous administration and must be handled and administered by qualified healthcare professionals experienced in oncology. It serves as a critical component in many multi-drug chemotherapy regimens designed to combat different malignancies.

Key Benefits

Effective in the systemic treatment of a broad spectrum of solid tumors and hematological cancers. An essential medication in established protocols for conditions such as breast cancer, lymphomas, gastric cancer, and ovarian cancer. Administered under strict medical supervision, ensuring precise dosage calculation and continuous patient monitoring for optimal therapeutic outcomes.

How to Use

1. Epirubicin HCl 2mg/mL 25mL solution is strictly for intravenous use only. 2. Administration must be performed by a licensed physician or a trained healthcare professional with expertise in cytotoxic drug administration. 3. The exact dosage, frequency, and duration of treatment will be determined by your treating physician based on your specific cancer type, stage, body surface area, and overall health status. 4. Close medical supervision, including regular monitoring of cardiac function, blood counts, and liver function, is mandatory throughout the course of treatment. 5. This medication is not intended for self-administration and should only be prepared and given in a clinical setting.

Caution & Warnings

  • Cardiotoxicity: There is a dose-dependent risk of developing cardiac dysfunction, including congestive heart failure. Regular monitoring of cardiac function (e.g., ECHO, MUGA scans) is crucial.
  • Myelosuppression: May cause severe bone marrow suppression, leading to significant reductions in white blood cells (leukopenia), red blood cells (anemia), and platelets (thrombocytopenia).
  • Extravasation Risk: If the solution leaks from the vein during infusion, it can cause severe local tissue necrosis and blistering. Immediate action is required if extravasation is suspected.
  • Secondary Malignancies: Patients treated with epirubicin may have an increased risk of developing secondary leukemias.
  • Pregnancy and Lactation: Epirubicin is contraindicated during pregnancy and breastfeeding due to its genotoxic and teratogenic potential. Effective contraception must be used by both male and female patients during and after treatment.
  • Liver and Kidney Impairment: Dosage adjustments are necessary for patients with hepatic or renal dysfunction.
  • Drug Interactions: Inform your physician of all other medications, including over-the-counter drugs, herbal supplements, and vitamins, as interactions may occur.
  • Immunosuppression: Avoid live vaccines during treatment due to immunosuppression.

Ingredients

Active Ingredient: Epirubicin Hydrochloride (2 mg per mL) Excipients: Water for Injection, Sodium Chloride, and possibly other inactive ingredients as per manufacturer's formulation.

Product Details

Form: Solution for Injection Route of Administration: Intravenous Strength: 2 mg/mL Volume per Vial: 25 mL Storage Conditions: Store refrigerated between 2°C and 8°C. Protect from direct light. Do not freeze. Ensure integrity of vial before use. Legal Status: Prescription Only Medicine (POM), dispensed and administered under strict medical guidance.
More Information
Gtin 30-355-04
Recommended Sale Price 240.25
Is Wasfaty Product No
Brand Not Defined
Ingredient Name EPIRUBICIN HYDROCHLORIDE
SFDA Reg. No 30-355-04
IBC 30-355-04
Drug Type Prescription
Scientific Name Epirubicin Hydrochloride
Strength 2 mg/mL
Strength Unit mg/mL
Form Solution for Injection
Admin Route Intravenous
Size 25
Size Unit ML
Package Types Vial
Package Size 1 vial
shelfLife 36 months
Storage conditions Store in a refrigerator (2°C to 8°C). Do not freeze. Protect from light.
Refrigerator Storage Yes